QEL-004

N/A

Report date: 2025/04/17 16:23:40

Base Information

Drug NameQEL-004
Drug Alias NamePan liver CARQEL-004
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsUpdating
Therapy Area/IndicationsRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuell Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQuell Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A